|
|
|
Volumn 10, Issue 8 Suppl 10, 2012, Pages 1-16
|
|
Antibody-drug conjugate technology development for hematologic disorders.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINOGLYCOSIDE;
ANTIBODY CONJUGATE;
ANTINEOPLASTIC AGENT;
CAC10 VCMMAE;
CAC10-VCMMAE;
DRUG DERIVATIVE;
GEMTUZUMAB;
INOTUZUMAB OZOGAMICIN;
LEUKOCYTE ANTIGEN;
MAYTANSINE;
MONOCLONAL ANTIBODY;
MORPHOLINE DERIVATIVE;
SAR 3419;
ARTICLE;
CLINICAL TRIAL (TOPIC);
HODGKIN DISEASE;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
LARGE CELL LYMPHOMA;
METHODOLOGY;
RECURRENT DISEASE;
AMINOGLYCOSIDES;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTIGENS, CD;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS AS TOPIC;
HODGKIN DISEASE;
HUMANS;
IMMUNOCONJUGATES;
IMMUNOTHERAPY;
LYMPHOMA, LARGE-CELL, ANAPLASTIC;
MAYTANSINE;
MORPHOLINES;
RECURRENCE;
|
|
EID: 84881518053
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
